Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study

Journal of Critical Care

Volumn 42, Issue , 2017, Pages 268-274

  Burry, Lisa D ^a   Williamson, David R ^b   Mehta, Sangeeta ^a   Perreault, Marc M ^c   Mantas, Ioanna ^a   Mallick, Ranjeeta ^d   Fergusson, Dean A ^d   Smith, Orla ^e   Fan, Eddy ^f   Dupuis, Sebastien ^b   Herridge, Margaret ^f   Rose, Louise ^g  

^a University of Toronto   (Canada)

^b HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^c MONTREAL GENERAL HOSPITAL   (Canada)

^d OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f UNIVERSITY OF TORONTO   (Canada)

^g SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Anticholinergic; Benzodiazepine; Delirium; Intensive care; Opioid

Indexed keywords

BENZODIAZEPINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; MIDAZOLAM; NEUROLEPTIC AGENT; OPIATE; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DELIRIUM; DISEASE ASSOCIATION; DISEASE BURDEN; DISEASE DURATION; DRUG EXPOSURE; DRUG IDENTIFICATION; DRUG POTENCY; ENVIRONMENTAL EXPOSURE; FEMALE; HEALTH CARE PLANNING; HOSPITAL MORTALITY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; NICOTINE REPLACEMENT THERAPY; OBSERVATIONAL STUDY; PROSPECTIVE STUDY; RISK FACTOR; SEDATION; TREATMENT OUTCOME; APACHE; CHEMICALLY INDUCED; CLINICAL TRIAL; CRITICAL ILLNESS; INTENSIVE CARE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; ONTARIO; OUTCOME ASSESSMENT; SURVIVAL ANALYSIS;

ANTIPSYCHOTIC AGENTS; APACHE; CRITICAL CARE; CRITICAL ILLNESS; DELIRIUM; FEMALE; HUMANS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MIDDLE AGED; ONTARIO; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 85038018314     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2017.08.003     Document Type: Article

References (42)

1. Pandharipande, P.P., Girard, T.D., Jackson, J.C., et al. Long-term cognitive impairment after critical illness. N Engl J Med 369 (2013), 1306–1316.
2. van den Boogaard, M., Schoonhoven, L., Evers, A.W., et al. Delirium in critically ill patients: impact on long-term health-related quality of life and cognitive functioning. Crit Care Med 40 (2012), 112–118.
3. Klein Klouwenberg, P.M., Zaal, I.J., Spitoni, C., et al. The attributable mortality of delirium in critically ill patients: prospective cohort study. BMJ, 349, 2014, g6652.
4. Ely, E.W., Shintani, A., Truman, B., et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA 291 (2004), 1753–1762.
5. Leslie, D.L., Marcantonio, E.R., Zhang, Y., et al. One-year health care costs associated with delirium in the elderly population. Arch Intern Med 168 (2008), 27–32 (Improvement IfH).
6. Gunther, M.L., Morandi, A., Ely, E.W., Pathophysiology of delirium in the intensive care unit. Crit Care Clin 24:viii (2008), 45–65.
7. Barr, J., Fraser, G.L., Puntillo, K., et al. Clinical practice guidelines for the management of pain, agitation, and Delirium in adult patients in the intensive care unit. Crit Care Med 41 (2013), 263–306.
8. Zaal, I.J., Devlin, J.W., Peelen, L.M., Slooter, A.J., A systematic review of risk factors for delirium in the ICU. Crit Care Med. 43 (2015), 40–47.
9. Han, L., McCusker, J., Cole, M., et al. Use of medications with anticholinergic effect predicts clinical severity of delirium symptoms in older medical inpatients. Arch Intern Med 161 (2001), 1099–1105.
10. Wolters, A.E., Zaal, I.J., Veldhuijzen, D.S., et al. Anticholinergic medication use and transition to Delirium in critically ill patients: a prospective cohort study. Crit Care Med 43 (2015), 1846–1852.
11. Pandharipande, P., Shintani, A., Peterson, J., et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology 104 (2006), 21–26.
12. Dubois, M.J., Bergeron, N., Dumont, M., et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 27 (2001), 1297–1304.
13. Morrison, R.S., Magaziner, J., Gilbert, M., et al. Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci 58 (2003), 76–81.
14. Van Rompaey, B., Elseviers, M.M., Schuurmans, M.J., et al. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care, 13, 2009, R77.
15. Svenningsen, H., Egerod, I., Videbech, P., et al. Fluctuations in sedation levels may contribute to delirium in ICU patients. Acta Anaesthesiol Scand 57 (2013), 288–293.
16. van den Boogaard, M., Pickkers, P., Slooter, A.J., et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ, 344, 2012, e420.
17. Pandharipande, P., Cotton, B.A., Shintani, A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J Trauma 65 (2008), 34–41.
18. Zaal, I.J., Devlin, J.W., Hazelbag, M., et al. Benzodiazepine-associated delirium in critically ill adults. Intensive Care Med 41 (2015), 2130–2137.
19. Burry, L.D., Williamson, D.R., Perreault, M.M., et al. Analgesic, sedative, antipsychotic, and neuromuscular blocker use in Canadian intensive care units: a prospective, multicentre, observational study. Can J Anesth 61 (2014), 619–630.
20. Riker, R.R., Picard, J.T., Fraser, G.L., Prospective evaluation of the sedation-agitation scale for adult critically ill patients. Crit Care Med 27 (1999), 1325–1329.
21. Bergeron, N., Dubois, M.J., Dumont, M., et al. Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27 (2001), 859–864.
22. Teasdale, G., Jennett, B., Assessment of coma and impaired consciousness. A practical scale. Lancet 2 (1974), 81–84.
23. Duran, C.E., Azermai, M., Vander Stichele, R.H., Systematic review of anticholinergic risk scales in older adults. Eur J Clin Pharmacol 69 (2013), 1485–1496.
24. Canada, A., Required organizational practices handbook 2014. 2014, Ottawa, Accreditation Canada.
25. Ouimet, S., Kavanagh, B.P., Gottfried, S.B., et al. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med 33 (2007), 66–73.
26. Knaus, W.A., Draper, E.A., Wagner, D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 13 (1985), 818–829.
27. Mehta, S., Burry, L., Fischer, S., et al. Canadian survey of the use of sedatives, analgesics, and neuromuscular blocking agents in critically ill patients. Crit Care Med 34 (2006), 374–380.
28. Mehta, S., Burry, L., Cook, D., et al. Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trial. JAMA 308 (2012), 1985–1992.
29. Mehta, S., Cook, D., Devlin, J.W., et al. Prevalence, risk factors, and outcomes of delirium in mechanically ventilated adults. Crit Care Med 43 (2015), 557–566.
30. Skrobik, Y., Leger, C., Cossette, M., et al. Factors predisposing to coma and delirium: fentanyl and midazolam exposure; CYP3A5, ABCB1, and ABCG2 genetic polymorphisms; and inflammatory factors. Crit Care Med 41 (2013), 999–1008.
31. Fraser, G.L., Devlin, J.W., Worby, C.P., et al. Benzodiazepine versus nonbenzodiazepine-based sedation for mechanically ventilated, critically ill adults: a systematic review and meta-analysis of randomized trials. Crit Care Med 41 (2013), S30–S38.
32. Malacrida, R., Fritz, M.E., Suter, P.M., et al. Pharmacokinetics of midazolam administered by continuous intravenous infusion to intensive care patients. Crit Care Med 20 (1992), 1123–1126.
33. Gaudreau, J.D., Gagnon, P., Harel, F., et al. Psychoactive medications and risk of delirium in hospitalized cancer patients. J Clin Oncol 23 (2005), 6712–6718.
34. Lawlor, P.G., Gagnon, B., Mancini, I.L., et al. Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study. Arch Intern Med 160 (2000), 786–794.
35. Pisani, M.A., Murphy, T.E., Araujo, K.L., et al. Benzodiazepine and opioid use and the duration of intensive care unit delirium in an older population. Crit Care Med 37 (2009), 177–183.
36. Agarwal, V., O'Neill, P.J., Cotton, B.A., et al. Prevalence and risk factors for development of delirium in burn intensive care unit patients. J Burn Care Res 31 (2010), 706–715.
37. McPherson, J.A., Wagner, C.E., Boehm, L.M., et al. Delirium in the cardiovascular ICU: exploring modifiable risk factors. Crit Care Med 41 (2013), 405–413.
38. Pisani, M.A., Murphy, T.E., Van Ness, P.H., et al. Characteristics associated with delirium in older patients in a medical intensive care unit. Arch Intern Med 167 (2007), 1629–1634.
39. Lat, I., McMillian, W., Taylor, S., et al. The impact of delirium on clinical outcomes in mechanically ventilated surgical and trauma patients. Crit Care Med 37 (2009), 1898–1905.
40. Lin, S.M., Huang, C.D., Liu, C.Y., et al. Risk factors for the development of early-onset delirium and the subsequent clinical outcome in mechanically ventilated patients. J Crit Care 23 (2008), 372–379.
41. Schreiber, M.P., Colantuoni, E., Bienvenu, O.J., et al. Corticosteroids and transition to delirium in patients with acute lung injury. Crit Care Med 42 (2014), 1480–1486.
42. Salluh, J.I., Wang, H., Schneider, E.B., et al. Outcome of delirium in critically ill patients: systematic review and meta-analysis. BMJ, 350, 2015, h2538.